Carvana Co. Announces Upsize and Pricing of Its Offering of Class A Common Stock
PHOENIX–(BUSINESS WIRE)–Carvana Co. (“Carvana”) (NYSE: CVNA), the leading e-commerce platform for buying and selling used…
PHOENIX–(BUSINESS WIRE)–Carvana Co. (“Carvana”) (NYSE: CVNA), the leading e-commerce platform for buying and selling used…
Singapore, Singapore–(Newsfile Corp. – April 21, 2022) – NELO’s goal is to reach gamers around…
TOKYO, Apr 22, 2022 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501, “Hitachi”) today announced…
TOKYO, Apr 22, 2022 – (JCN Newswire) – Fujitsu, Dentsu Inc. (subsidiary of Dentsu Group…
SINGAPORE, Apr 22, 2022 – (ACN Newswire) – Catalist-listed AcroMeta Group Limited (ACROMETA; SGX: 43F),…
LA JOLLA, Calif., April 21, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
INDIANAPOLIS–(BUSINESS WIRE)–Governor Eric J. Holcomb joined local officials and executives from Intelinair, an agbioscience company,…
enaible expands its leadership team with the newly-created position of Chief Revenue Officer to scale…
VANCOUVER, BC , April 21, 2022 (GLOBE NEWSWIRE) — via InvestorWire — AREV Life Sciences…
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) — via InvestorWire — AREV Life Sciences…
WATERTOWN, Mass., April 21, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
Montrouge, France, April 21, 2022Ordinary and Extraordinary General Meeting of May 12, 2022 Procedures for…
SAN FRANCISCO, April 21, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
LEXINGTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
HOLLISTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
REDWOOD CITY, Calif., April 21, 2022 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading…
CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company…
REDWOOD CITY, Calif., April 21, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
First patient dosed in ReSPECT-LM Phase 1/2a dose escalation trial of 186RNL for leptomeningeal metastases…
JERSEY CITY, N.J., April 21, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (Nasdaq: SCYX) today announced…